129, and will not be elaborated here. Figure 5: The chromatin-associated small interfering RNA (siRNA) pathway in Arabidopsis thaliana. At present, there are no generally accepted examples of ...

RNA interference (RNAi), the process by which double-stranded RNA (dsRNA) is processed into small interfering RNAs (siRNAs) that silence homologous transcripts, is both a fascinating cellular ...

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

中心体是微管组织中心，在细胞分裂中发挥着关键作用。中心体RNA（cnRNAs）在多个物种中已被发现存在，并被证实在许多物种的细胞分裂过程中精确调控基因表达的时空动态。然而，目前尚不清楚秀丽隐杆线虫（C. elegans）中是否存在中心体RNA及其具体功能。近日，中国科学技术大学生命科学与医学部光寿红团队在Science China ...

They observed that introducing double-stranded RNA (dsRNA) into the worm led to the silencing of genes with complementary ... it is possible to develop highly specific and effective treatments with ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Both microRNAs and the related class of small interfering RNAs (siRNAs) are small snippets of RNA—just 21 or 22 nucleotides long—that bind to specific messenger RNAs (mRNAs) and repress them.

H.C. Wainwright analyst Patrick Trucchio reiterates a Buy rating and $75 price target on Silence Therapeutics (SLN) shares following a recent ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

Benitec has a market cap of $250mn, $67.8mn in cash, and a cash runway of over 10 quarters, but faces risks due to its small ...